~~<i id='E0EBF287A1'><strike id='E0EBF287A1'><tt id='E0EBF287A1'><pre id='E0EBF287A1'></pre></tt></strike></i>~~

Home» explore» hotspot

hotspot

author：fashion 2025-09-30 23:24:53 Page View：369

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Lilly’s obesity pill cuts 15% of weight at highest dose in mid
Next article： Medical leaders decry Supreme Court decision on affirmative action

comprehensive

What does generative AI mean for health care? We asked experts

MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

Why failed clinical trials don’t always spell doom for a new drug

AdobeThisarticlewasadaptedfromSTAT’slatestreport,“Failedtrial,successfuldrug:howanegativereadoutcans

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

1:03FormerPresidentDonaldTrumpspeaksbeforeheboardshisplaneatRonaldReaganWashingtonNationalAirport,Au